|
Volumn 471, Issue 7339 SUPPL., 2011, Pages
|
Chemoprevention: First line of defence
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
AMINOLEVULINIC ACID;
ANTINEOPLASTIC AGENT;
CELECOXIB;
DICLOFENAC;
EFLORNITHINE;
FLUOROURACIL;
IMIQUIMOD;
PHOTOFRIN;
RALOXIFENE;
ROFECOXIB;
SULINDAC;
TAMOXIFEN CITRATE;
UNCLASSIFIED DRUG;
WART VIRUS VACCINE;
ZYCLARA;
CANCER;
CARCINOGEN;
DRUG;
RESEARCH WORK;
RODENT;
ARTICLE;
CANCER CELL;
CANCER COMBINATION CHEMOTHERAPY;
CANCER PREVENTION;
CANCER RISK;
CANCER THERAPY;
CARCINOGENESIS;
CHEMOPROPHYLAXIS;
COLON CANCER;
GENETIC ANALYSIS;
HUMAN;
INFLAMMATION;
LOW DRUG DOSE;
METASTASIS;
NONHUMAN;
PRIORITY JOURNAL;
ANIMALS;
ASPIRIN;
CLINICAL TRIALS, PHASE II AS TOPIC;
COLONIC NEOPLASMS;
CYCLOOXYGENASE INHIBITORS;
DISEASE MODELS, ANIMAL;
DISEASE PROGRESSION;
FEMALE;
FOCAL ADHESION PROTEIN-TYROSINE KINASES;
GENISTEIN;
HUMANS;
INFLAMMATION;
MALE;
MATRIX METALLOPROTEINASE 2;
MICE;
NEOPLASM METASTASIS;
NEOPLASMS;
NEOVASCULARIZATION, PATHOLOGIC;
POLYAMINES;
PRECANCEROUS CONDITIONS;
PROSTATIC NEOPLASMS;
PYRAZOLES;
RISK ASSESSMENT;
SULFONAMIDES;
|
EID: 79953055619
PISSN: 00280836
EISSN: 14764687
Source Type: Journal
DOI: 10.1038/471S5a Document Type: Article |
Times cited : (43)
|
References (6)
|